ADVFN - Advanced Financial Network.
HOME» NASDAQ » P » PRGO Stock Price » PRGO Stock News

Perrigo Company Share News

 Perrigo Company (mm) Stock Price
PRGO Stock Price
 Perrigo Company (mm) Stock Chart
PRGO Stock Chart
 Perrigo Company (mm) Stock News
PRGO Stock News
 Perrigo Company (mm) Company Information
PRGO Company Information
 Perrigo Company (mm) Stock Trades
PRGO Stock Trades

Perrigo Deal For Paddock Won't Close Until FY2012 On FTC Probe

DOW JONES NEWSWIRES Perrigo Co. (PRGO) said its deal to purchase privately-held generic pharmaceutical products maker Paddock Laboratories Inc. won't close in the current quarter as previously expected, as it continues to work through a lengthy review process with the U.S. Federal Trade Commission. Perrigo, a seller of store-brand pharmaceutical and nutrition supplements, had announced in January it would pay $540 million to acquire the assets of Minneapolis-based Paddock. It said then that it expected the transaction to add 25 cents to its adjusted earnings and $200 million to sales in the company's fiscal 2012 year. Wednesday, the company said it now expects the Paddock deal to close in fiscal 2012. Due to the extended horizon, Perrigo will incur 20 cents of deal-related intangible amortization and 15 cents of other acquisition-related costs, hurting earnings by roughly 10 cents a share. The company also reiterated Wednesday its expectations for a tax benefit of $95 million related to the acquisition of Paddock's assets. Last month, Perrigo reported its fiscal third-quarter earnings rose 43% as recent acquisitions helped boost the company's sales. Its acquisition of Orion Laboratories Pty Ltd., for instance, added $7 million in incremental sales to its consumer healthcare unit. Shares were down 0.3% in recent trading at $86.26. Year to date, the stock is up 36%. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Perrigo Company (PRGO)
DateTimeHeadline
05/31/201317:48:24TECH STOCKS: Losses Wash Over Tech Stocks At The Close
05/31/201312:06:12TECH STOCKS: Apple, Netflix Among Advancers As Techs Rise
02/01/201309:29:03U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
11/15/201220:03:21Correction to Reckitt Benckiser Offers to Buy Schiff Story
10/16/201209:42:07Perrigo Gets Tentative Approval from FDA to Market Heartburn...
09/06/201212:44:34Teva Sues Perrigo Over Patent for ProAir Inhaler -Bloomberg
01/12/201210:05:19Perrigo: US Court Finds Generic Mucinex Doesn't Infringe Patents
07/26/201116:30:28FTC To Require Perrigo To Sell 6 Drugs As Part Of Paddock Deal
06/29/201110:07:45Perrigo Deal For Paddock Won't Close Until FY2012 On FTC Probe
05/13/201113:05:24FDA Panel Will Review Acetaminophen Dosing For Children, Infants
06/29/201008:54:31Perrigo Gets Exclusive US Rights For Generic Version Of Allegra
01/20/201014:15:12FDA Denies Reckitt's Request On Generic Mucinex Applications

Perrigo Company and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad